Upvote
Downvote
Research / Senior Research Associate, Non - Viral Delivery
Share Job
- Suggest Revision
- Many of our programs are derived from our TRACER AAV capsid discovery platform, which we have used to generate novel capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing.
- Some of our programs are wholly owned, and some are advancing with partners including Alexion, AstraZeneca Rare Disease; Novartis Pharma AG; Neurocrine Biosciences, Inc.; and Sangamo Therapeutics, Inc. For more information, visit www.
- As a gene therapy company, Voyager is constantly engineering novel AAV capsids which are changing the face of gene therapy for neurological diseases.
- on the Non-Viral Delivery team, you will be responsible for experimental design and execution, data analysis, and communication of experimental results leveraging binding moieties, such as antibody and peptide carriers, for these cell surface receptors, as well as supporting efforts to bring this science to new therapeutic programs.
- Prior experience with recombinant protein engineering/optimization is a plus.
Active Job
Updated 13 days agoSimilar Job
Relevance
Active